Search & Filter
Date Range
Resource Type
HRS Endorsed
Audience
Topic
Product
Manufacturer
Device Type
FDA Class
Clinical Guidelines
2003 International Consensus on Nomenclature and Classification of Atrial Fibrillation
This consensus statement provides a simple way to characterize an episode of atrial fibrillation.
April 1, 2003
Clinical Guidelines
2003 Policy Statement on Catheter Ablation: Personnel, Policy, Procedures, and Therapeutic Recommendations
This policy statement provides updates about the rationale and indications for catheter ablative procedures and recommendations regarding electrophysiology laboratory personnel and facilities.
March 1, 2003
Clinical Guidelines
2003 NASPE Standards of Professional Practice for the Allied Professional in Pacing and Electrophysiology
The provision of services accompanying technology-based electrophysiological-related interventions created an opportunity for health care professionals to specialize in the field of cardiac rhythm management.
January 1, 2003
Clinical Trials
The DAVID Trial
For patients with standard indications for ICD therapy, no indication for cardiac pacing, and an LVEF of 40% or less, dual-chamber pacing offers no clinical…
December 25, 2002
Clinical Trials
The AFFIRM Trial
A comparison of rate control and rhythm control in patients with atrial fibrillation.
December 5, 2002
Clinical Guidelines
2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices
The focus of these guidelines is the appropriate use of devices (pacemakers and implantable cardioverter-defibrillators), not the treatment of cardiac arrhythmias.
September 1, 2002
Clinical Trials
The MOST Trial
For sinus-node dysfunction, while dual-chamber pacing does not improve stroke-free survival compared with ventricular pacing, dual-chamber pacing does reduce the risk of atrial fibrillation, signs…
June 13, 2002
Clinical Guidelines
2002 NASPE Expert Consensus Conference: Radiofrequency Catheter Ablation in Children with and without Congenital Heart Disease
Based on the Consensus Conference held during the 21st Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology (NASPE), this consensus statement…
June 1, 2002
Clinical Trials
The MADIT II Trial
Implantable cardioverter-defibrillator (ICD) therapy is superior to conventional medical therapy in reducing the risk of death among patients with prior myocardial infarction and reduced ejection…
March 21, 2002
Clinical Guidelines
2002 NASPE Position Statement: The Revised NASPE/BPEG Generic Code for Antibradycardia, Adaptive-Rate, and Multisite Pacing
February 1, 2002—This statement provides the revised NBG code, endorsed by the British…
February 1, 2002